Hosted on MSN3h
Ozempic Could Get Way Too Expensive Under Trump—Here's What You Can Do
President Trump’s proposed tariffs on Denmark could have costly consequences for Americans relying on GLP-1 medications like ...
Newsable Asianet News on MSN7h
We Asked Retail Traders About Eli Lilly’s Biggest Post-Q4 Risk — Most Say It’s The Weight-Loss Drug Wars
Shares of Eli Lilly finished Thursday 3% higher despite an earnings report that showed sales of its blockbuster GLP-1 ...